MICAD adds 18 new agents

Justine Varieur Cadet | | Health Imaging | Molecular Imaging
The Molecular Imaging and Contrast Agent Database (MICAD) program has added 18 new contrast and in vivo molecular imaging agents for research and development in molecular imaging, which is available free online.

The new agents are:

PET Agents:
  • 2-Cl-[11C]-(-)-NPA target: D3 dopamine receptors
  • [18F]Fluoropropyl-Tanaproget target: Progesterone receptor (PR)
  • [18F]AV-45 target: Amyloid-beta peptide
  • [18F]FE@SUPPY target: Adenosine A3 receptors
  • 18-[18F]Fluoro-4-thia-palmitate target: Fatty acid oxidation (FAO) enzymes
  • 18-[18F]Fluoro-4-thia-oleate target: Fatty acid oxidation (FAO) enzymes
  • 68Ga-HBED-CC-anti-EpCAM diabody Target: Epithelial cell adhesion molecule (EpCAM)
  • [68Ga]3 target: Prostate-specific membrane antigen (PSMA)
  • 89Zr-DFO-J591 target: Prostate-specific membrane antigen (PSMA)

SPECT Agents:
  • 111In-Monomeric [Tyr3]octreotide target: Somatostatin receptors (SSTRs)
  • 111In-Dimeric [Tyr3]octreotide target: Somatostatin receptors (SSTRs)
  • [125I]SIB-NuB2i and [125I]SIB-NuB2iii target: CD20

Ultrasound Agents:
  • MB-Knottin target: avB3, avB5, and a5B1 integrin receptors

Optical Agents:
  • PEG-S-Au/SPIO target: Non-targeted
  • CR2-Fc-SPIO target: Complement C3 fragments

Multimodality Agents:
  • Gd-DTPA-PLGA target: Non-targeted
  • Au@GdL target: Non-targeted
  • Au@DTDTPA-Gd target: Non-targeted

All 929 agents are available in the MICAD database.

Justine Varieur Cadet

Related Content

Researchers receive grant worth millions to develop portable PET scanner
Why is the US still dependent on foreign medical isotope production?
Downed high-flux reactor could restart sooner than anticipated
Some nuc med departments are already feeling the strain of the isotope shortage
NorthStar opens facility to assist with development and distribution of vital radioisotopes
Lizard saliva could be key to spotting elusive pancreatic tumors

Around the web

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services.